Tri-Source Pharma hired a firm to lobby on "drug pricing law." Photo: Bill Clark/CQ Roll Call via Getty Images

Tri-Source Pharma has hired its first lobbying firm, Mercury Strategies, to influence federal "drug pricing law and regulation," according to a lobbying disclosure from this month. Tri-Source is the parent of NextSource Biotechnology, a firm that was heavily criticized after the Wall Street Journal reported it has hiked the price of its off-patent cancer pill by 1,400% since 2013.

The bottom line: President Trump's drug plan won't really change how drug companies set their list prices, but those firms still want a seat at the table. Tri-Source, which filed lawsuits against critics earlier this year, and Mercury Strategies did not answer multiple phone calls.

Go deeper

FDA chief vows agency will not accept political pressure on coronavirus vaccine

Food and Drug Administration Commissioner Stephen Hahn promised that "science will guide our decision" for a coronavirus vaccine at a Senate hearing on Wednesday.

Why it matters: More Americans are expressing doubt about a first-generation vaccine, despite President Trump's efforts to push an unrealistic timeline that conflicts with medical experts in his administration.

CEO confidence rises for the first time in over 2 years

Data: Business Roundtable; Chart: Naema Ahmed/Axios

A closely-watched CEO economic confidence index rose for the first time after declining for nine straight quarters, according to a survey of 150 chief executives of the biggest U.S. companies by trade group Business Roundtable.

Why it matters: The index, which still remains at a decade low, reflects corporate America's expectations for sales, hiring and spending — which plummeted amid uncertainty when the pandemic hit.

Official says White House political appointees "commandeered" Bolton book review

John Bolton's book "The Room Where it Happened." Photo: Chris Delmas/AFP via Getty Images

A former career official at the National Security Council claims her pre-publication review of former national security adviser John Bolton's explosive book on President Trump was "commandeered by political appointees for a seemingly political purpose," according to a letter from her lawyers filed in court on Tuesday.

Why it matters: The White House fought against the publication of Bolton's book for most of the year on the grounds that it contained harmful and "significant amounts of classified information."

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!